Notably, SLC38A5 downregulation is associated with defective mitosis and an increased proportion of cells in the S and G2/M phases [37], mirroring the effects observed after knocking down CDH17 in CRC cells. The gene discussed is SLC38A5; the disease is colorectal carcinoma.